RPS6KB1 and lung adenocarcinoma: We therefore investigated the association with survival and response to chemotherapy by performing IHC for total P70S6K in a cohort of 52 lung adenocarcinoma patients that all received a neoadjuvant chemotherapy regimen containing platinum-based chemotherapy (Figure 4C, Supplementary file 4).